{"organizations": [], "uuid": "c85ca095420c2a949a87ff52722e12b1bf7296e4", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027/page/2", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/03/26/globe-newswire-scapa-healthcare-acquires-biomed-laboratories.html", "country": "US", "domain_rank": 767, "title": "Scapa Healthcare Acquires BioMed Laboratories", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.219, "site_type": "news", "published": "2018-03-26T16:00:00.000+03:00", "replies_count": 0, "uuid": "c85ca095420c2a949a87ff52722e12b1bf7296e4"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/03/26/globe-newswire-scapa-healthcare-acquires-biomed-laboratories.html", "ord_in_thread": 0, "title": "Scapa Healthcare Acquires BioMed Laboratories", "locations": [], "entities": {"persons": [], "locations": [{"name": "windsor", "sentiment": "none"}, {"name": "conn.", "sentiment": "none"}, {"name": "dallas", "sentiment": "none"}], "organizations": [{"name": "scapa healthcare acquires biomed laboratories", "sentiment": "negative"}, {"name": "scapa healthcare", "sentiment": "negative"}, {"name": "scapa", "sentiment": "none"}, {"name": "biomed laboratories", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "WINDSOR, Conn., March 26, 2018 (GLOBE NEWSWIRE) -- Scapa Healthcare , a trusted strategic outsource partner of skin-friendly, turnkey solutions, today announced the acquisition of Dallas, TX-based BioMed Laboratories. BioMed is a leading business-to-business developer and manufacturer of topical skin care solutions for advanced wound care, ostomy and consumer wellness markets.\nServing similar customer bases, BioMed is Scapa Healthcare’s first adjacent platform. The acquisition broadens Scapa’s offerings beyond adhesive-based solutions to now include complementary skin care offerings such as tubed hydrogel, wound cleansers, moisturizers and more. BioMed’s portfolio of products includes gels, creams, lotions, liquids, powders and hot fill waxes.\nThe addition of BioMed strengthens Scapa Healthcare’s offerings to its customers in the advanced wound care and ostomy markets, and expands market accessibility within consumer wellness segments such as OTC, first aid and health and beauty.\n“At Scapa Healthcare, we remain committed to being the trusted strategic outsource partner of choice for our customers,” said Joe Davin, President Scapa Healthcare. “The acquisition of BioMed is in line with our continued growth strategy. We continue to expand our capabilities and product offerings while maintaining the level of excellence our partners expect.”\nBioMed’s quality system is certified to ISO 13485 standards, and complies with FDA cGMP, Health Canada and EU regulatory requirements.\nFor more information on the acquisition, please visit http://www.scapa.com/en/news/AcquisitionofBioMedLaboratoriesLLC .\nLearn more about BioMed Laboratories\nAbout Scapa Healthcare\nScapa Healthcare is a global trusted strategic outsource partner of skin-friendly turnkey solutions for advanced wound care, consumer wellness and medical device markets. Scapa Healthcare partners with market leaders to design, develop, manufacture and commercialize innovative skin contact solutions to meet end-user needs. Scapa Healthcare offers turn-key development services, including design and project management; coating; converting, perforation and assembly; printing and packaging; and sterilization services. For more information, visit: www.scapahealthcare.com\nMedia Contact Jordan Bouclin SVM Public Relations and Marketing Communications Jordan.bouclin@svmpr.com (401) 490-9700 Scapa Healthcare Contact Scapa Healthcare Marketing Communications Manager Bethany.Schivley@scapa.com (860) 902-8157\nSource:Scapa Healthcare", "external_links": ["https://www.globenewswire.com/Tracker?data=tuFczR7vkWmgsw0kXHMGoNSiEFG4JTZ_NLfyfm8Zq9DdFuO5ZpmZjvqRCDwOPsmcK6hPOfc0UnfCfeMUfs41y-Ic7Ff0-zQJKgBJk59E1lZ-FfA727rbUNitY9XNC8JJ", "https://www.globenewswire.com/Tracker?data=oxh-s1x_4p2jQJKuQjetcB5WSpzc6_2uIYTBupwQkUcCCJFcYElLoSjwFQttlEMYKKEhES9m3mWxdGjcMWVFO1OCA8wnnt9-3_j8mOa0iOdCkmOFxtpC-PXl66XbGq1dLZwwlWKWDhd4xQxrQwqNTmrp7iACE9lhYvkOEFkyT-B9BkUSh1pEXp17kvYwd5Jrvpbg0RMSxrvty5Zl5ZZOWA==", "https://www.globenewswire.com/Tracker?data=lvIoUBG5YW2nGadLdKNvNL10VfQk7pwqeP-IdJdNsgE6-MWGtqdUg4x81b2CHB08UBX11ovZpKFbK9I2xPm2AVIv4EcCy-xUIGOu34NSBGE=", "http://www.scapa.com/en/news/AcquisitionofBioMedLaboratoriesLLC", "https://www.globenewswire.com/Tracker?data=ZINo7z_CiMffPsI9lUhIOW4zFgYuL-7R7TOwUZUQIKy1oJP2fUa-ArHXWyoVMgfsr0CKX2lkbtE5PVjE5Kj3Rxt_sOGCGK4JNtqziCC1Mso=", "https://www.globenewswire.com/NewsRoom/AttachmentNg/f6041e78-5e7d-4746-b160-cd1d6592f72e"], "published": "2018-03-26T16:00:00.000+03:00", "crawled": "2018-03-26T16:39:03.003+03:00", "highlightTitle": ""}